6
Oct
2026

Coriolis Pharma Research GmbH

Exhibitor at CPHI Milan 2026 stand 10G24, CRO
About Us

Coriolis Pharma is a globally operating contract research and development organization (CRDO) and the premier partner for drug product development, analytical, and manufacturing services across a vast array of therapeutic modalities, including antibodies, peptides, therapeutic proteins, cell and gene therapy, nucleic acids and more.

We focus on liquid and lyophilized drug products and provide our services under both, R&D and GMP conditions.
 
Our expert scientists design and execute our platform and custom services to accelerate and derisk your path to market.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    Germany
  • On CPHI since:
    2022
  • Certificates:
    1
  • Employees:
    100 - 249
Company types
Contract Research Organisation (CRO)
Primary activities
Analytical Services
Biopharmaceutical
Contract Research Organisation
Laboratory Services
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 10G24, CRO

Products Featured at CPHI Milan 2026

  • Analytical Services (GMP and R&D)

    Product Analytical Services (GMP and R&D)

    Our analytical portfolio comprises 200+ different techniques – all performed by Coriolis’ experts in-house. Our offering includes:
    • Aggregate analytics • Particle characterization • Particle identification • Surfactant characterization • Higher order structure analysis • Funcional assays • Chemi...
  • Manufacturing Services

    Product Manufacturing Services

    We support our clients with the production of non-GMP drug product batches for preclinical and indicative stability studies, including
    • Liquid drug product manufacturing • Lyophilized drug product manufacturing • Analytics and stability testing
  • Formulation Development

    Product Formulation Development

    We develop phase-appropriate formulations for liquid, frozen and lyophilized drug products, focusing on your target product profile (TPP) and designing the study to meet your requirements.

    Our offering includes:


    - Preformulation Screening
    - Preclinical Formulation Development
    -...
  • Lyophilization Process Develpment and Lyo Modelling

    Product Lyophilization Process Develpment and Lyo Modelling

    Coriolis Pharma’s team of experts specializes in lyophilization, bringing extensive experience in developing, optimizing, scaling up, and transferring lyophilization cycles for biopharmaceutical drug products. Our advanced approaches are designed to create robust, economical freeze-drying cycles by impleme...
  • Stability Studies (Non-GMP and GMP)

    Product Stability Studies (Non-GMP and GMP)

    As part of formulation development projects, supply of preclinical, clinical or commercial material, or as a standalone service package, Coriolis performs stability studies in accordance with ICH guidelines using suitable climate chambers at controlled temperatures and relative humidity (RH). In addition t...

Coriolis Resources (1)